Catalyst Pharmaceuticals And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Catalyst Pharmaceuticals (CPRX), SPS Commerce (SPSC), Farmers National Banc Corp. (FMNB) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Catalyst Pharmaceuticals (CPRX)

61.5% sales growth and 28.55% return on equity

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Earnings Per Share

As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.71.

PE Ratio

Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 23.51. Meaning, the purchaser of the share is investing $23.51 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.55%.

Volume

Today’s last reported volume for Catalyst Pharmaceuticals is 430635 which is 81.71% below its average volume of 2355730.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 116.7% and 50%, respectively.

2. SPS Commerce (SPSC)

17.3% sales growth and 10.63% return on equity

SPS Commerce, Inc. provides cloud-based supply chain management solutions worldwide. It offers solutions through the SPS Commerce, a cloud-based platform that enhances the way retailers, suppliers, grocers, distributors, and logistics firms manage and fulfill omnichannel orders, optimize sell-through performance, and automate new trading relationships. The company also provides Fulfillment solution that provides fulfillment automation and replaces or augments an organization's existing staff and trading partner electronic communication infrastructure by enabling easy compliance with retailers' rulebooks, automatic, and digital exchange of information among numerous trading partners through various protocols, and greater visibility into the journey of an order; and Analytics solution, which consists of data analytics applications that enables customers to enhance their visibility across supply chains through greater analytics capabilities. In addition, it offers various complimentary products, such as assortment product, which enables accurate order management and rapid fulfillment; and community product that accelerates vendor onboarding and ensures trading partner adoption of new supply chain requirements. The company was formerly known as St. Paul Software, Inc. and changed its name to SPS Commerce, Inc. in May 2001. SPS Commerce, Inc. was incorporated in 1987 and is headquartered in Minneapolis, Minnesota.

Earnings Per Share

As for profitability, SPS Commerce has a trailing twelve months EPS of $1.28.

PE Ratio

SPS Commerce has a trailing twelve months price to earnings ratio of 116.5. Meaning, the purchaser of the share is investing $116.5 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.63%.

Volume

Today’s last reported volume for SPS Commerce is 16758 which is 88.45% below its average volume of 145162.

3. Farmers National Banc Corp. (FMNB)

16.4% sales growth and 15.85% return on equity

Farmers National Banc Corp., a financial holding company, operates in the banking, trust, retirement consulting, insurance, and financial management industries. It offers commercial and retail banking services, including checking, savings, and time deposit accounts; commercial, mortgage and installment, and home equity loans; home equity lines of credit, night depository, safe deposit box, money order, bank check, automated teller machine, Internet banking, travel card, E bond transaction, MasterCard and Visa credit cards, brokerage, and other services. The company also provides personal and corporate trust services in the areas of estate settlement, trust administration, and employee benefit plans; retirement services; property and casualty insurance products and services; and various insurance products through licensed representatives, as well as invests in municipal securities. It operates through 47 locations in northeastern region of Ohio and one location in southwestern Pennsylvania. The company was founded in 1887 and is based in Canfield, Ohio.

Earnings Per Share

As for profitability, Farmers National Banc Corp. has a trailing twelve months EPS of $1.82.

PE Ratio

Farmers National Banc Corp. has a trailing twelve months price to earnings ratio of 7.14. Meaning, the purchaser of the share is investing $7.14 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.85%.

Volume

Today’s last reported volume for Farmers National Banc Corp. is 210610 which is 36.78% above its average volume of 153969.

4. Simulations Plus (SLP)

10.8% sales growth and 6.14% return on equity

Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for noncompartmental analysis and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers KIWI, a cloud-based web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; RENAsym for investigating and predicting drug-induced or acute kidney injury; IPFsym, a software tool to treat or cure idiopathic pulmonary fibrosis; and the Monolix Suite, a solution for modeling and simulation. Further, the company provides population modeling and simulation contract research services; and clinical-pharmacology-based consulting services in support of regulatory submissions. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. The company was founded in 1996 and is headquartered in Lancaster, California.

Earnings Per Share

As for profitability, Simulations Plus has a trailing twelve months EPS of $0.52.

PE Ratio

Simulations Plus has a trailing twelve months price to earnings ratio of 80.6. Meaning, the purchaser of the share is investing $80.6 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.14%.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Jan 26, 2023, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 0.58%.

5. Brinks Company (BCO)

6.1% sales growth and 44.92% return on equity

The Brink's Company provides secure transportation, cash management, and other security-related services in North America, Latin America, Europe, and internationally. The company offers armored vehicle transportation of valuables; automated teller machine (ATM) management services, such as cash replenishment, replenishment forecasting, cash optimization, ATM remote monitoring, service call dispatching, transaction processing, installation, and first and second line maintenance services; network infrastructure; and cash-in-transit services. It also provides transportation services for diamonds, jewelry, precious metals, securities, bank notes, currency, high-tech devices, electronics, and pharmaceuticals; vault outsourcing and money processing services; and services related to deploying and servicing intelligent safes and safe control devices, as well as cashier balancing, counterfeit detection, account consolidation, electronic reporting, check imaging, and reconciliation services. In addition, the company offers technology applications, including online cash tracking, cash inventory management, and other web-based tools. Further, it provides bill payment acceptance and processing services; prepaid cards and corporate debit cards; and security system design and installation services that include alarms, motion detectors, closed-circuit televisions, and digital video recorders, as well as access control systems comprising card and biometric readers, electronic locks, and turnstiles. Additionally, the company offers monitoring services; and security and guarding services to protect airports, offices, warehouses, stores, and public venues. It serves banks and financial institutions, retailers, government agencies, mints, jewelers, and other commercial operations. The company was formerly known as The Pittston Company and changed its name to The Brink's Company in May 2003. The Brink's Company was founded in 1859 and is headquartered in Richmond, Virginia.

Earnings Per Share

As for profitability, Brinks Company has a trailing twelve months EPS of $3.63.

PE Ratio

Brinks Company has a trailing twelve months price to earnings ratio of 18.69. Meaning, the purchaser of the share is investing $18.69 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 44.92%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Brinks Company’s EBITDA is 1.32.

Yearly Top and Bottom Value

Brinks Company’s stock is valued at $67.83 at 11:22 EST, under its 52-week high of $70.05 and way higher than its 52-week low of $48.38.

Moving Average

Brinks Company’s worth is higher than its 50-day moving average of $62.41 and way higher than its 200-day moving average of $58.59.

Leave a Reply

Your email address will not be published. Required fields are marked *